Metabolic Diseases

Interconnected cardiovascular, renal, and metabolic (CRM) diseases are the leading cause of death worldwide and account for up to 20 million deaths annually (GBD 2015 Mortality and Causes of Death Collaborators. Lancet. 2016;388(10053):1459–544).  By following the science, we are targeting specific pathways to address the interconnected nature of these diseases. Building on our expertise in developing innovative treatments for CRM conditions, our goal is to improve the lives of people living with these diseases, their families and the healthcare system.

Metabolic Diseases
Metabolic Infographic

 

About interconnected cardiovascular, renal, and metabolic (CRM) conditions

We have unwavering optimism that our expertise will provide new solutions for cardiovascular, renal and metabolic diseases.

 

Positioning in Cardiovascular, Renal and Metabolic Diseases 


Our mission is to protect people from the consequences of cardiovascular, renal and metabolic diseases, and advocate for a shift from fragmented to integrated solutions that focus on prevention and treatment.   

NP-IE-100721    February 2024